CAMDEN, N.J. – A former Atlantic County resident now living
in Florida admitted defrauding New Jersey state health benefits programs out of
millions of dollars by submitting fraudulent claims for medically unnecessary
prescriptions, U.S. Attorney Craig Carpenito and N.J. Attorney General Gurbir
S. Grewal announced.
Robert Madonna, 36, pleaded guilty before U.S. District
Judge Robert B. Kugler in Camden federal court to an information charging him
with conspiracy to commit health care fraud.
According to documents filed in this case and statements
made in court:
Compounded medications are supposed to be specialty
medications mixed by a pharmacist to meet the specific medical needs of an
individual patient. Although compounded drugs are not approved by the Food and
Drug Administration (FDA), they are properly prescribed when a physician
determines that an FDA-approved medication does not meet the health needs of a
particular patient, such as if a patient is allergic to a dye or other ingredient.
Madonna was one of the owners of a company formed to market
prescription compounded medications, referred to as Company 1. From May 2015
through February 2016, Madonna and others associated with the company persuaded
individuals in New Jersey to obtain very expensive and medically unnecessary
compounded medications.
The conspirators
learned that certain compound medication prescriptions – including pain, scar,
and antifungal creams, as well as vitamin combinations – were reimbursed for
thousands of dollars for a one-month supply. The conspirators also learned that
the N.J. State Health Benefits Program, which covers qualified state and local
government employees, retirees, and eligible dependents, and the School
Employees’ Health Benefits Program, which covers qualified local education
employees, retirees, and eligible dependents, would cover compound medication
prescriptions.
Madonna and his conspirators entered into an agreement under
which Company 1 would receive a percentage of the amounts paid to compounding
pharmacies for prescriptions secured by Madonna and his conspirators. Madonna
and his conspirators then recruited public employees, offered them hundreds of
dollars per month, and persuaded them to agree to obtain prescription
compounded medications without any examination by a medical professional that
the medications were medically necessary. Madonna would obtain insurance and
personal information from the public employees and give that information to
conspirators. A doctor then would call the public employees and complete the
prescription without personally examining the employees or having a prior
doctor/patient relationship with them. Company 1 would receive a percentage of
the amounts paid on these fraudulent prescriptions, which Madonna and others
would divide.
According to the information, Madonna and his conspirators
caused New Jersey to pay more than $2 million in fraudulent claims for
compounded medications for public employees.
Madonna received $179,370 in gross proceeds for his role in
the scheme. As part of his plea
agreement, Madonna must forfeit these criminal proceeds and pay restitution of
at least $2,092,791.
Madonna faces a maximum penalty of 10 years in prison and a
$250,000 fine, or twice the gross gain or loss from the offense. Sentencing is scheduled for Feb. 5, 2019.
U.S. Attorney Carpenito credited agents of the FBI’s
Atlantic City Resident Agency, under the direction of Special Agent in Charge
Gregory W. Ehrie in Newark; IRS – Criminal Investigation, under the direction
of Special Agent in Charge John Tafur in Newark: and the U.S. Department of
Labor, Office of Inspector General, New York Region, under the direction of
Special Agent in Charge Michael C. Mikulka, with the investigation leading to
today’s guilty plea. He also thanked the Division of Pensions and Financial
Transactions in the State Attorney General’s Office, under the direction of
Attorney General Grewal and Division Chief Eileen Schlindwein Den Bleyker, for
its assistance in the investigation.
The government is represented by Assistant U.S. Attorneys R.
David Walk, Jr. and Jacqueline M. Carle of the U.S. Attorney’s Office in
Camden.
No comments:
Post a Comment